Potassium inwardly-rectifying channel subfamily J member 9 (KCNJ9)

Potassium inwardly-rectifying channel subfamily J member 9 (KCNJ9), also known as GIRK3 or Kir3.3, is a subunit of the G protein-activated inwardly rectifying potassium (GIRK) channel family. It is an integral membrane protein that typically forms heterotetrameric complexes with other GIRK subunits, such as GIRK1 or GIRK2, to modulate neuronal excitability. Upon activation by the beta-gamma subunits of G proteins following the stimulation of Gi/o-coupled receptors, the channel facilitates the efflux of potassium ions, leading to membrane hyperpolarization and the inhibition of action potential firing. KCNJ9 is widely expressed in the central nervous system, particularly in regions associated with reward and pain processing, such as the ventral tegmental area and the periaqueductal gray. Genetic studies have linked KCNJ9 variation to susceptibility to substance use disorders, including ethanol and opioid addiction, as well as differences in analgesic drug response and seizure susceptibility. Pharmacological modulation of KCNJ9, through agonists or inhibitors, is being explored as a potential therapeutic strategy for treating chronic pain, addiction, and certain neurological disorders by selectively tuning inhibitory neurotransmission.

Other names

GIRK3Kir3.3G protein-activated inward rectifier potassium channel 3KIP3KIR3.3

Activation by G-protein beta-gamma subunits leads to potassium efflux and membrane hyperpolarization; pharmacological modulation involves either direct agonism to increase inhibitory tone or antagonism to block the channel pore and increase excitability.